Vendor, Minneapolis, MN
National Institute for Pharmaceutical Technology & Education Inc.
UEI RKVKGV1CJDB8, CAGE 4XQ36
2 awards and $1,517,240 obligated between July 14, 2026 and August 20, 2026, 100% under full and open competition, against 83.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40126C00054Definitive Contract, July 14, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Eo 14398 FY26 Baa: National Institute for Pharmaceutical Technology & Education (Baa Fy26c1bp4)NAICS 541715, PSC AJ12 | $1,517,240 |
| 75F40122C00192Definitive Contract, August 20, 2026, Full and Open Competition, 165 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Eo 14398 - the Purpose of This Modification Is To: the Vendor Requests an Extension of 12 Months for This Project.NAICS 541714, PSC AN11 | $0 |
- Product and service codes
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied ResearchAN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 2 awards